Syndax Pharmaceuticals, Inc. (SNDX)
19.62
-0.28
(-1.38%)
USD |
NASDAQ |
May 27, 16:00
19.62
0.00 (0.00%)
After-Hours: 16:33
Syndax Pharmaceuticals Free Cash Flow : -278.35M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cogent Biosciences, Inc. | -286.27M |
| Vera Therapeutics, Inc. | -293.81M |
| Biogen, Inc. | 2.316B |
| Amgen, Inc. | 8.597B |
| Ardelyx, Inc. | -37.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -50.34M |
| Cash from Investing (Quarterly) | 38.39M |
| Cash from Financing (Quarterly) | 7.918M |
| Free Cash Flow Per Share (Quarterly) | -0.5704 |
| Free Cash Flow to Equity (Quarterly) | -50.27M |
| Free Cash Flow to Firm (Quarterly) | -38.50M |
| Free Cash Flow Yield | -16.28% |